Elkan R. Gamzu
Chairman at NeuroHealing Pharmaceuticals, Inc.
Elkan R. Gamzu active positions
Companies | Position | Start | End |
---|---|---|---|
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | Chairman | - | - |
Career history of Elkan R. Gamzu
Former positions of Elkan R. Gamzu
Companies | Position | Start | End |
---|---|---|---|
W WORL | Director/Board Member | 2000-01-31 | 2008-01-02 |
BioPharmAnalysis LLC
BioPharmAnalysis LLC Miscellaneous Commercial ServicesCommercial Services BioPharmAnalysis LLC provides scientific, medical, and technology due diligence consulting and advisory services. The private company is based in New York, NY. The company was founded by Elkan R. Gamzu. | Founder | - | - |
Corporate Officer/Principal | - | - | |
Warner-Lambert Pharmaceutical Research Institute | Corporate Officer/Principal | - | - |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | President | - | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
REDHILL BIOPHARMA LTD. | Corporate Officer/Principal | 2011-02-20 | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Chief Executive Officer | 2008-07-24 | - |
President | 2008-07-24 | - | |
Hypnion, Inc.
Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Director/Board Member | 2003-03-16 | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Elkan R. Gamzu
University of Pennsylvania | Doctorate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Statistics
International
United States | 11 |
Israel | 3 |
Operational
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
President | 2 |
Sectoral
Health Technology | 8 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
W WORL | Health Technology |
REDHILL BIOPHARMA LTD. | Health Technology |
Private companies | 8 |
---|---|
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Hypnion, Inc.
Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Commercial Services |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Warner-Lambert Pharmaceutical Research Institute | |
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA. | Health Technology |
BioPharmAnalysis LLC
BioPharmAnalysis LLC Miscellaneous Commercial ServicesCommercial Services BioPharmAnalysis LLC provides scientific, medical, and technology due diligence consulting and advisory services. The private company is based in New York, NY. The company was founded by Elkan R. Gamzu. | Commercial Services |
- Stock Market
- Insiders
- Elkan R. Gamzu
- Experience